Human Anthelmintics
Human Anthelmintics is a pharmacological intervention comprising chemical agents or biological substances formulated specifically for the treatment of parasitic worm infections in humans, distinguished from veterinary or broad-spectrum anthelmintics by its targeted application, safety profile, and regulatory approval for human clinical use.
377
Publications
14.8K
Citations
1.5K
Authors
422
Institutions
Publications per year
2017–2026
60
Parents
377
1–5 of 377
1.5K
Swiss Tropical and Public Health Institute, Switzerland
13 publications · 404 citations
11
h-index
6
h-index
5
h-index
Commonwealth Scientific and Industrial Research Organisation, Australia
5 publications · 235 citations
5
h-index
5
h-index
1–5 of 1.5K
422

University of Basel
Basel, Switzerland
12 h-index
49 publications
1.4K citations
Swiss Tropical and Public Health Institute
Allschwil, Switzerland
12 h-index
44 publications
1.3K citations

Commonwealth Scientific and Industrial Research Organisation
Canberra, Australia
10 h-index
24 publications
1K citations

McGill University
Montreal, Canada
10 h-index
21 publications
1.1K citations
North Eastern Hill University
Shillong, India
7 h-index
20 publications
872 citations
London School of Hygiene & Tropical Medicine
London, United Kingdom
6 h-index
17 publications
871 citations

The University of Queensland
Brisbane, Australia
5 h-index
14 publications
788 citations
Bayer (Germany)
Leverkusen, Germany
5 h-index
9 publications
340 citations
1–8 of 422
30 publications · 1.8K citations
21
h-index
23 publications · 828 citations
15
h-index
19 publications · 733 citations
15
h-index
Repository · 19 publications · 608 citations
14
h-index
12 publications · 706 citations
12
h-index
1–5